Table 3 Age distribution of new hepatocellular carcinoma cases in each quarter.
From: Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019
Age | First quarter (1996–2001) n = 4311 | Second quarter (2002–2007) n = 5505 | Third quarter (2008–2013) n = 5776 | Fourth quarter (2014–2019) n = 4955 |
|---|---|---|---|---|
< 60 years n = 3711 (18.1%) | 994 (23.0%) | 1181 (21.5%) | 955 (16.5%) | 581 (11.7%) |
60–69 years n = 6652 (32.4%) | 1839 (42.7%) | 1697 (30.8%) | 1690 (29.3%) | 1426 (28.8%) |
70–79 years n = 7448 (36.2%) | 1292 (30.0%) | 2179 (39.6%) | 2227 (38.6%) | 1750 (35.3%) |
≥ 80 years n = 2736 (13.3%) | 186 (4.3%) | 448 (8.1%) | 904 (15.6%) | 1198 (24.2%) |
Mean | 65.4 ± 9.2 | 67.4 ± 9.8 | 69.5 ± 10.1 | 71.5 ± 10.1 |
P-value | - | P < 0.0001 (vs. First quarter) | P < 0.0001 (vs. Second quarter) | P < 0.0001 (vs. Third quarter) |
